UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000004482 |
|---|---|
| Receipt number | R000005362 |
| Scientific Title | Phase II Study of Adoptive Immunotherapy Comprising 2-Methyl-3-Butenyl-1-Pyrophosphate-Stimulated Gamma Delta T Cells, Teceleukin, and Zoledronic acid in Patients With Stage IV Renal Cell Carcinoma |
| Date of disclosure of the study information | 2011/01/15 |
| Last modified on | 2014/06/23 10:32:49 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2010/10/30 13:38:56 | ||
| 2 | Update | 2010/11/26 20:42:49 | Date of disclosure of the study information |
|
| 3 | Update | 2011/01/17 17:49:14 | Recruitment status |
|
| 4 | Update | 2014/06/23 10:28:01 | TEL Last name of contact person Last name of contact person Address Address Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
| 5 | Update | 2014/06/23 10:32:49 | Recruitment status |
